Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
Gaurav Mehta from Industrial Alliance Securities issued a price target of $1.25 for SACH on 2025-03-28 11:13:23.The adjusted price target was set to $1.25.At the time of the announcement,...
March 28, 2025 SACH -4.31%
from Roth Capital issued a price target of $5.40 for MGRM on 2025-03-18 11:46:08.The adjusted price target was set to $5.40.At the time of the announcement, MGRM...
March 18, 2025 MGRM -4.08%
from Industrial Alliance Securities issued a price target of $1.75 for ASRT on 2025-03-14 11:03:06.The adjusted price target was set to $1.75.At the time of the announcement,
March 18, 2025 ASRT 1.85%
from Morgan Stanley issued a price target of $5.00 for TSVT on 2025-03-14 10:52:55.The adjusted price target was set to $5.00.At the time of the announcement, TSVT...
March 18, 2025 TSVT 0.20%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| SPWH Sportsman's Warehouse Hol | 1.91
97.93% | ||||||||||||||||||
| JSPRW Jasper Therapeutics Inc | 0.13
62.17% | ||||||||||||||||||
| ALLK Allakos Inc. | 0.32
48.06% | ||||||||||||||||||
| SCLX Scilex Holding Company | 0.30
25.26% | ||||||||||||||||||
| ADAP Adaptimmune Therapeutics | 0.31
22.00% | ||||||||||||||||||
| BNGO Bionano Genomics, Inc. | 3.75
20.97% | ||||||||||||||||||
| ATAI Atai Life Sciences N.V. | 1.48
19.35% | ||||||||||||||||||
| DBVT DBV Technologies S.A. | 7.70
19.20% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 2.70%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW 3.15%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -0.50%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK 5.94%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 0.48%